Found: 5
Select item for more details and to access through your institution.
Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 5, p. 1213, doi. 10.1007/s10637-021-01096-4
- By:
- Publication type:
- Article
Differential sensitivity of RIP3-proficient and deficient murine fibroblasts to camptothecin anticancer drugs.
- Published in:
- Acta Pharmacologica Sinica, 2012, v. 33, n. 3, p. 426, doi. 10.1038/aps.2012.1
- By:
- Publication type:
- Article
Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: Synthesis and biological characterization.
- Published in:
- Acta Pharmacologica Sinica, 2011, v. 32, n. 5, p. 664, doi. 10.1038/aps.2011.7
- By:
- Publication type:
- Article
Increased PARP1‐DNA binding due to autoPARylation inhibition of PARP1 on DNA rather than PARP1‐DNA trapping is correlated with PARP1 inhibitor's cytotoxicity.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 3, p. 714, doi. 10.1002/ijc.32131
- By:
- Publication type:
- Article
Acquired resistance of phosphatase and tensin homolog‐deficient cells to poly(ADP‐ribose) polymerase inhibitor and Ara‐C mediated by 53BP1 loss and SAMHD1 overexpression.
- Published in:
- Cancer Science, 2018, v. 109, n. 3, p. 821, doi. 10.1111/cas.13477
- By:
- Publication type:
- Article